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Abstract
Introduction: We report a case of a patient with marked eosinophilia and neutrophilia as a manifestation of a
spindle cell sarcoma.
Case presentation: A 41-year-old African American woman presented with an enlarging, painful mass in her right
knee area. Four years previously, she had had a mass similar to this diagnosed as an osteosarcoma, and had
undergone a radical resection and hinge-knee replacement. Before the surgery, she was treated with neoadjuvant
docetaxel and gemcitabine. A biopsy was taken from the recurrent mass, and histological examination revealed
high-grade soft-tissue sarcoma. The patient received no further treatment. Complete blood counts revealed a white
blood cell (WBC) count of 13.6 to 17.9 × 10
9/L, with neutrophils being 8.2 to 10.9 × 10
9/L and eosinophils 1.8 to
1.9 × 10
9/L. At readmission six months later, WBC was 126.7 × 10
9/L, with neutrophils being 57.02 × 10
9/L and
eosinophils 60.82 × 10
9/L. The eosinophils peaked at 77.79 × 10
9/L two days later. Evaluations for allergies,
infection, and autoimmune mechanisms were negative. Bone marrow revealed increased eosinophils without
blasts. After resection, blood counts abruptly decreased to the normal range. Pathology confirmed high-grade
spindle cell sarcoma. Approximately one year after resection, the patient was readmitted with metastatic disease to
her lungs. During this presentation, her eosinophil and neutrophil count was again increased. WBC was 107.8 ×
10
9/L, with eosinophil count of 47.43 × 10
9/L and neutrophil count of 44.10 × 10
9/L. Interleukin-5 was normal, and
granulocyte–macrophage colony-stimulating factor (GM-CSF) was elevated at 208.8 (normal < 4.8).
Conclusion: In our case, the patient had eosinophilia and neutrophilia associated with a spindle cell sarcoma,
possibly representing a paraneoplastic syndrome secondary to GM-CSF. There were no signs of infectious, allergic,
or autoimmune causes for the eosinophilia or neutrophilia. Even though the occurrence of eosinophilia and
neutrophilia with malignancy is rare, patients who have either condition without an apparent cause should be
checked for malignancy.
Introduction
Eosinophilia can be a manifestation of a variety of
causes, such as infections, drug reactions, allergic reac-
tions, and autoimmune processes. It has also been
described in relation to neoplasm as demonstrated by
Isaacson and Rapoport in 1941, who presented 34 cases
of neoplasm associated with eosinophilia [1]. Since then,
there has been an accepted association of eosinophilia
with hematologic malignan c i e ss u c ha sl y m p h o m aa n d
leukemia. Eosinophilia has also been noted in a myriad
of primary tumors such as cancer of the liver, breast,
uterus, and ovaries [2]. The association of eosinophilia
and sarcomas, however, is rare. Neutrophilic leukemoid
reactions, which are more common than eosinophilia,
can also be difficult to diagnose with differentials includ-
ing common etiologies sucha si n f e c t i o n sa n ds o l i d
malignancies, and uncommonc a u s e ss u c ha sc h r o n i c
neutrophilic leukemia [3].
Sarcomas are very rare malignancies, making up
approximately 1% of adult malignancies and 15% of pedia-
tric malignancies. They can occur at any site of the body,
and arise primarily from mesenchymal structures [4].
Osteosarcoma is the most common type of sarcoma of the
bone. Spindle cell sarcomas are very closely related to
osteosarcomas, except that ostioid is not produced in spin-
dle cell sarcomas. They are treated in a similar fashion.
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ciated with spindle cell sarcoma probably representing a
paraneoplastic syndrome. There were no signs of infec-
tious, allergic, or autoimmune causes for the patient’se o s i -
nophilia or neutrophilia.
Case presentation
A 41-year-old African American woman presented with
an enlarging, painful mass in the right knee area. She
had a history of osteosarcoma in her right leg diagnosed
four years previously, and had undergone radical resec-
tion and hinge-knee replacement at another hospital.
She had also been treated with neoadjuvant docetaxol
and gemcitabine before her resection.
Owing to her history of osteosarcoma, we took a
biopsy from the mass, which was diagnosed histologi-
cally as a recurrent, high-grade soft tissue sarcoma.
Laboratory investigations revelaed white blood cell
(WBC) count of 13.6 to 17.9 × 10
9/L, neutrophils 8.2 to
10.9 × 10
9/L, and eosinophils 1.8 to 1.9 × 10
9/L (refer-
e n c er a n g eW B C3 . 3t o1 0 . 7×1 0
9/L, neutrophils 1.6 to
7.2 × 10
9/L, eosinophils 0.0 to 0.5 × 10
9/L). The patient
received no further treatment and was discharged.
Our patient returned six months later with increased
pain in her right leg, and marked growth of the leg
mass. She also reported a decreased range of motion
secondary to the right knee mass. On physical examina-
tion, we found a large mass in the right knee area
approximately 150 × 200 mm in size, which was hard,
fixed and tender. Owing to the size, there was markedly
decreased range of motion. There was no pedal edema,
and peripheral pulses were intact. There was also an
enlarged (15 × 20 mm), hard, slightly tender lymph
node in the right inguinal area. There was no rash.
There was no loss of sensation distal to the mass.
Laboratory investigations revealed WBC 126.7 × 10
9/L,
neutrophils 57.02 × 10
9/L, and eosinophils 60.82 × 10
9/
L. The eosinophil level peaked two days later at 77.79 ×
10
9/L (Table 1, Figure 1).
Owing to her massive eosinophilia and neutrophilia,
our patient underwent bone marrow biopsy to exclude
leukemia and demonstrate a lack of myeloid clonality.
The bone marrow revealed eosinophilia and neutrophilia
without increased blast cells. Testing for JAK2 mutation
was negative as was flow cytometry. Other investigations
included: IgE (3 IU/mL), C3 (174 mg/dL), C4 (35 mg/
dL), haemolytic complement (CH) (276 units) (normal
ranges 0 to 120 IU/mL, 65 to 190 mg/dL, 15 to 50 mg/
dL, 100 to 300 units, respectively). Testing for anti-
neutrophil cytoplasmic antibody was negative. Our
patient then underwent amputation of her right leg
mass, and lymph node excision of her palpable inguinal
lymph nodes. Results showed high-grade spindle cell
sarcoma with metastasis in three of six lymph nodes.
Five days after surgery, our patient’sb l o o dc o u n t s
returned essentially to normal (WBC 11.0 × 10
9/L, neu-
trophils 6.6 × 10
9/L, and eosinophils 0.4 × 10
9/L).
Approximately one year later, our patient returned to
the hospital for a recurrence of her previously resected
osteosarcoma. At this time, she had metastatic disease to
the lungs and once again had elevated blood counts: WBC
107.8 × 10
9/L, neutrophils 49.59 × 10
9/L and eosinophils
47.43 × 10
9/L. Interleukin (IL)-5 was 5.0 pg/mL (normal <
10). Granulocyte–macrophage colony-stimulating factor
(GM-CSF was elevated at 208.8 pg/mL (normal < 4.8).
Our patient decided to have no further intervention for
her metastatic disease and to receive palliative care only.
Discussion
Eosinophilia is defined as mild (350 to 1,500 cells/μL),
moderate (1,500 to 5000 cells/uL), or severe (>5,000 cells/
μL). It can occur in several disorders such as drug reac-
tions, allergic diseases, and infections. It has also been
shown to occur in malignancies, with most occurring in
hematologic cases [2]. In 1946, 34 cases of eosinophilia
associated with neoplasm were presented by Isaacson and
Rapoport [2]. Since then, there have been numerous
reports of eosinophilia associated with hematologic
Table 1 Complete blood count (×10
9/L)
Hospital day WBC Neutrophils Lymphocytes Monocytes Eosinophils
1 126.7 57.02 2.53 6.34 60.82
2 118.3 48.5 1.18 3.55 65.06
3 116.8 35 2.1 4 70
4 112.1 29.61 2.9 5.22 77.79
5 95.7 40.19 3.83 1.91 49.76
6 51.1 29.13 5.62 3.58 11.24
7 20.1 11.6 3.6 2.4 2
8 19.3 11.1 4.3 2.6 1
9 11 6.6 2.8 1.1 0.4
WBC = white blood cells.
Snyder and Lauter Journal of Medical Case Reports 2010, 4:335
http://www.jmedicalcasereports.com/content/4/1/335
Page 2 of 4cancers and primary neoplasm of the breast, liver, uterus
and ovaries [2,5,6]. Neutrophilic leukemoid reactions have
also been documented with malignancies [3]. However,
the association of eosinophilia with sarcomas is very rare,
with only a few cases reported in the literature. Eosinophi-
lia has been reported in two cardiac rhabdomyosarcomas,
a chest wall sarcoma, an alveolar sarcoma, an undifferen-
tiated embryonal sarcoma, and two uterine leiomyosarco-
mas (Table 2) [5-12]. To the best of our knowledge, it has
never been reported in the literature with a spindle cell
sarcoma.
A number of hypotheses have been put forward
regarding the etiology for eosinophilia associated with
malignancy. These include the release of protein mate-
rial from necrosis of the tumor causing an eosinophilo-
tactic response, the release of chemotactic factors for
eosinophils from tumor cells, the seeding of metastatic
tumor cells to the bone marrow causing production of
eosinophils, and the stimulation of bone marrow cells to
produce eosinophils by eosinophilotactic factors
produced by the tumor cells [13]. It is not know if eosi-
nophilia is a good or poor prognostic sign, as eosinophi-
lia with neoplasm has been associated with both positive
and negative prognostic significance [14]. Peripheral
eosinophilia has been associated with a worse prognostic
sign than tissue eosinophilia, which could have a better
prognosis [9].
Eosinophils are produced from pluripotent stem cells
in the bone marrow guided through the eosinophil line-
age by cytokines and growth factors. There are several
cytokines and growth factors that can be involved in the
production of eosinophils, with the main cytokines
being IL-3 and IL-5, and the main growth factor being
GM-CSF [15]. These factors have been shown to induce
eosinophil production in vitro.I L - 3a n dG M - C S Fh a v e
activity on other cells as well, but IL-5 is more specific
for eosinophils [15]. These products have also been
shown to increase in relation to malignancies with per-
ipheral eosinophilia. Because GM-CSF is not specific for
eosinophils, it can also induce production of other cell
lines, causing neutrophilic leukemoid reactions.
Conclusion
Our patient had eosinophilia and neutrophilia associated
with a spindle cell sarcoma, possibly representing a
paraneoplastic syndrome secondary to GM-CSF. There
were no signs of infectious, allergic, or autoimmune
causes for the eosinophilia or neutrophilia. Even though
the occurrence of eosinophilia and neutrophilia with
malignancy is rare, patients who have either with no
apparent cause should be screened for malignancy.
Consent
Written informed consent for publication could not be
o b t a i n e df r o mt h ep a t i e n ta st h ep a t i e n ti sd i e da n dt h e
Figure 1 The number of white blood cells (WBC), eosinophils, and neutrophils before and after surgery.
Table 2 Reported cases of eosinophilia associated with
sarcomas
Location/Type of Sarcoma Author Year
Alveolar soft-part sarcoma Almansori, et al. 2005
Angiosarcoma Zeitouni, et al. 2002
Cardiac Rhabdomyosarcoma Sullivan, et al. 1983
Cardiac Rhabdomyosarcoma Lo Re III, et al. 2003
Chest wall sarcoma Hussain, et al. 1994
Embryonal sarcoma O’Sullivan, et al. 2001
Uterine Leiomyosarcoma Buka, et al. 1965
Uterine Leiomyosarcoma Ral, et al. 2003
Uterine Leiomyosarcoma Onishi, et al. 2005
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Page 3 of 4next-of-kin could not be contacted despite all reasonable
attempts. However, every effort has been made to pro-
tect patient anonymity and there is no reason to think
that the patient or family would object to publication.
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